King of Prussia, PA
Omnicare Clinical Research announced that it has opened an office in Seoul, Korea.
“Since 2006, we have been conducting studies in South Korea with a local partner,” said Benoit Martin, President, International for Omnicare Clinical Research. “Opening our own office in Seoul enables us to strengthen our presence in the Asia Pacific Region, as well as reinforce our global commitment to our clients. The new facility will also create added value in response to the Japanese Authorities’ mandate to provide data outside of Japan.”
Omnicare Clinical Research has had a presence in the Asia Pacific Region since its Australia office opened in 1985. The company has other offices in the area including: Beijing and Shanghai, China; Singapore; Taipei, Taiwan; Tokyo, Japan; and Bangalore, India.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.